Top Regenerative Medicine Companies in China

RE-Stem Biotech focuses on the research and development of cell therapies that harness the body's healing power to repair and regenerate tissues, specifically targeting conditions like osteoarthritis, spinal cord injuries, and various cancers. Their proprietary interventions, such as RE-EnableTM, highlight their commitment to innovative regenerative medicine solutions.

Beike Biotechnology is a leading provider of stem cell treatments, emphasizing its commitment to advancing the field of regenerative medicine through collaborations with governments and clinicians. The company focuses on the research, development, and clinical application of adult stem cells, positioning itself as a key player in this innovative medical area.

Regencell Bioscience is dedicated to improving the lives of patients, particularly in the treatment of ADHD and ASD. Their commitment to advancing healthcare aligns with the principles of regenerative medicine.

WuXi AppTec is a global leader in R&D and manufacturing services that supports the pharmaceutical and healthcare industries in advancing discoveries, particularly in cell and gene therapies. The company has received FDA approval to manufacture a key therapy for advanced melanoma, highlighting its commitment to delivering innovative treatments.

Gracell Biotechnologies is focused on developing innovative CAR-T cell therapies, which are a key aspect of regenerative medicine, aimed at providing fast and durable responses for cancer and autoimmune disease patients. Their advanced autologous platform enhances T cell activity through next-day manufacturing, promising to unlock the potential of cell therapy.

GeneMedi Vision focuses on developing innovative solutions for the therapeutics and diagnostics industry, particularly in gene therapy. Their use of advanced manufacturing techniques and novel AAV design positions them to address the evolving needs of the biologics sector.

OncoGenerix specializes in injectable process development and manufacturing, offering a comprehensive suite of services that ensures compliance with major regulatory standards. Their focus on advanced aseptic manufacturing technology and a robust quality management system positions them as a key player in the production of high-quality injectable products.

The company specializes in physiotherapy and rehabilitation equipment, offering a wide range of medical devices that may include solutions relevant to regenerative medicine. With over twenty years of experience and a commitment to innovation, they aim to be a leading manufacturer in this field.

CARsgen is a biopharmaceutical company focused on developing innovative cell therapies, including its lead candidate, zevorcabtagene autoleucel, a CAR T-cell product for treating multiple myeloma. With a strong manufacturing presence in both China and the U.S., CARsgen aims to advance regenerative medicine through its robust product pipeline and commitment to making cancer curable.

Evive Biotech is focused on developing innovative biological therapies, particularly in oncology and inflammatory diseases, utilizing proprietary technology platforms. Their commitment to advancing novel drug candidates and building a robust product pipeline positions them as a key player in addressing unmet medical needs.